Interview with the CEO of Galena Biopharma about cancer vaccines

February 8, 2016- Interviewed by Steven E. Greer, MD

We spoke with the CEO of Galena Biopharma, Mark Schwartz, PhD about cancer vaccines, and why this strategy is finally succeeding in clinical trial.

This entry was posted in - Biotech, Oncology. Bookmark the permalink.

Leave a Reply

Your email address will not be published.